After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Amphastar Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Amphastar Pharmaceuticals Inc is $1.26B. A total of 0.51 million shares were traded on the day, compared to an average of 414.08K shares.
In the most recent transaction, Zhou Rong sold 9,787 shares of AMPH for 26.20 per share on Dec 17 ’25. After the transaction, the SENIOR EVP, PRODUCTION CENTER now owns 138,043 company shares. In a previous transaction on Dec 12 ’25, Petersen Floyd F. sold 2,426 shares at 25.92 per share. AMPH shares that Director owns now total 71,368.
Among the insiders who sold shares, Petersen Floyd F. disposed of 1,737 shares on Dec 11 ’25 at a per-share price of $25.69. This resulted in the Director holding 73,794 shares of AMPH after the transaction. In another insider transaction, Floyd Petersen bought 4,163 shares at $80.00 per share on Dec 11 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AMPH has a high of $40.74 and a low of $20.39.
As of this writing, AMPH has an earnings estimate of $0.92 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $1.0 per share and a lower estimate of $0.8. The company reported an EPS of $0.92 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AMPH’s latest balance sheet shows that the firm has $136.67M in Cash & Short Term Investments as of fiscal 2021. There were $104.66M in debt and $103.81M in liabilities at the time. Its Book Value Per Share was $16.76, while its Total Shareholder’s Equity was $445.52M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMPH is Buy with a score of 3.63.
